Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
Open Access
- 23 June 2009
- journal article
- Published by Springer Nature in Breast Cancer Research
- Vol. 11 (3), R39
- https://doi.org/10.1186/bcr2326
Abstract
We evaluated whether CK19, one of the main cytoskeleton proteins of epithelial cells, is released as full-length protein from viable tumor cells and whether this property is relevant for metastatic progression in breast cancer patients.Keywords
This publication has 44 references indexed in Scilit:
- Cancer micrometastasesNature Reviews Clinical Oncology, 2009
- Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor CellsJNCI Journal of the National Cancer Institute, 2009
- MCF-7 breast carcinoma cells do not express caspase-3Breast Cancer Research and Treatment, 2008
- Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?Clinical Cancer Research, 2008
- Detection and Characterization of Putative Metastatic Precursor Cells in Cancer PatientsClinical Chemistry, 2007
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissuesProceedings of the National Academy of Sciences, 2006
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerNew England Journal of Medicine, 2005
- The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell linesInternational Journal of Cancer, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- INTERMEDIATE FILAMENTS: Structure, Dynamics, Function and DiseaseAnnual Review of Biochemistry, 1994